vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Farmland Partners Inc. (FPI). Click either name above to swap in a different company.
Farmland Partners Inc. is the larger business by last-quarter revenue ($20.7M vs $19.2M, roughly 1.1× Apyx Medical Corp). Farmland Partners Inc. runs the higher net margin — 103.4% vs -6.8%, a 110.2% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -3.5%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 31.4%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Farmland Industries was the largest agricultural cooperative in North America when it eventually sold all of its assets in 2002–04. During its 74-year history, Farmland served its farmer membership as a diversified, integrated organization, playing a significant role in agricultural markets both domestically and worldwide.
APYX vs FPI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $20.7M |
| Net Profit | $-1.3M | $21.4M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | — |
| Net Margin | -6.8% | 103.4% |
| Revenue YoY | 34.7% | -3.5% |
| Net Profit YoY | 71.9% | -63.5% |
| EPS (diluted) | — | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $20.7M | ||
| Q3 25 | $12.9M | $11.3M | ||
| Q2 25 | $11.4M | $10.0M | ||
| Q1 25 | $9.4M | $10.3M | ||
| Q4 24 | $14.2M | $21.5M | ||
| Q3 24 | $11.5M | $13.3M | ||
| Q2 24 | $12.1M | $11.4M | ||
| Q1 24 | $10.2M | $12.0M |
| Q4 25 | $-1.3M | $21.4M | ||
| Q3 25 | $-2.0M | $483.0K | ||
| Q2 25 | $-3.8M | $7.6M | ||
| Q1 25 | $-4.2M | $2.0M | ||
| Q4 24 | $-4.6M | $58.7M | ||
| Q3 24 | $-4.7M | $1.8M | ||
| Q2 24 | $-6.6M | $-2.0M | ||
| Q1 24 | $-7.6M | $1.4M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | 4.3% | ||
| Q2 25 | -22.6% | 78.2% | ||
| Q1 25 | -32.4% | 20.6% | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | 13.9% | ||
| Q2 24 | -45.7% | -17.9% | ||
| Q1 24 | -64.6% | 11.9% |
| Q4 25 | -6.8% | 103.4% | ||
| Q3 25 | -15.4% | 4.3% | ||
| Q2 25 | -33.2% | 76.3% | ||
| Q1 25 | -44.0% | 19.9% | ||
| Q4 24 | -32.5% | 273.6% | ||
| Q3 24 | -40.9% | 13.5% | ||
| Q2 24 | -54.0% | -17.5% | ||
| Q1 24 | -74.0% | 11.5% |
| Q4 25 | — | $0.44 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $1.09 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | $-0.19 | $-0.06 | ||
| Q1 24 | $-0.22 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | $161.6M |
| Stockholders' EquityBook value | $14.5M | $467.4M |
| Total Assets | $66.8M | $719.1M |
| Debt / EquityLower = less leverage | 2.58× | 0.35× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | $161.6M | ||
| Q3 25 | $37.5M | $170.4M | ||
| Q2 25 | $37.5M | $193.4M | ||
| Q1 25 | $37.5M | $202.6M | ||
| Q4 24 | $37.5M | $204.6M | ||
| Q3 24 | $37.5M | $394.0M | ||
| Q2 24 | — | $393.0M | ||
| Q1 24 | — | $383.0M |
| Q4 25 | $14.5M | $467.4M | ||
| Q3 25 | $5.8M | $457.3M | ||
| Q2 25 | $7.3M | $473.5M | ||
| Q1 25 | $10.5M | $492.2M | ||
| Q4 24 | $14.2M | $494.6M | ||
| Q3 24 | $11.0M | $519.4M | ||
| Q2 24 | $14.7M | $521.5M | ||
| Q1 24 | $20.3M | $526.7M |
| Q4 25 | $66.8M | $719.1M | ||
| Q3 25 | $57.4M | $738.5M | ||
| Q2 25 | $58.2M | $776.7M | ||
| Q1 25 | $60.2M | $810.5M | ||
| Q4 24 | $64.8M | $869.6M | ||
| Q3 24 | $60.7M | $1.0B | ||
| Q2 24 | $65.4M | $1.0B | ||
| Q1 24 | $70.7M | $1.0B |
| Q4 25 | 2.58× | 0.35× | ||
| Q3 25 | 6.41× | 0.37× | ||
| Q2 25 | 5.17× | 0.41× | ||
| Q1 25 | 3.57× | 0.41× | ||
| Q4 24 | 2.64× | 0.41× | ||
| Q3 24 | 3.40× | 0.76× | ||
| Q2 24 | — | 0.75× | ||
| Q1 24 | — | 0.73× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $17.4M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | 0.81× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $17.4M | ||
| Q3 25 | $-3.5M | $-2.0M | ||
| Q2 25 | $-1.2M | $-2.2M | ||
| Q1 25 | $-702.0K | $6.4M | ||
| Q4 24 | $-2.9M | $16.1M | ||
| Q3 24 | $-4.4M | $-4.3M | ||
| Q2 24 | $-4.3M | $-6.1M | ||
| Q1 24 | $-6.3M | $11.9M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | -4.04× | ||
| Q2 25 | — | -0.29× | ||
| Q1 25 | — | 3.12× | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | -2.39× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 8.66× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
